|
[1]BATALLER R, BRENNER DA.Liver fibrosis[J].J Clin Invest, 2005, 115 (2) :209-218.
|
|
[2]DUARTE S, BABER J, FUJII T, et al.Matrix metalloproteinases in liver injury, repair and fibrosis[J].Matrix Biol, 2015, 44-46:147-156.
|
|
[3]ROBERT S, GICQUEL T, VICTONI T, et al.Involvement of matrix metalloproteinases (MMPs) and inflammasome pathway in molecular mechanisms of fibrosis[J].Biosci Rep, 2016, 36 (4) :e00360.
|
|
[4]NIE QH, DUAN GR, LUO XD, et al.Expression of TIMP-1 and TIMP-2 in rats with hepatic fibrosis[J].World J Gastroenterol, 2004, 10 (1) :86-90.
|
|
[5]EBRAHIMI H, NADERIAN M, SOHRABPOUR AA.New concepts on pathogenesis and diagnosis of liver fibrosis;a review article[J].Middle East J Dig Dis, 2016, 8 (3) :166.
|
|
[6]KOCABAYOGLU P, LADE A, LEE YA, et al.β-PDGF receptor expressed by hepatic stellate cells regulates fibrosis in murine liver injury, but not carcinogenesis[J].J Hepatol, 2015, 63 (1) :141-147.
|
|
[7]FAN TT, HU PF, WANG J, et al.Regression effect of hepatocyte nuclear factor 4αon liver cirrhosis in rats[J].J Dig Dis, 2013, 14 (6) :318-327.
|
|
[8]MURPHY FR, ISSA R, ZHOU X, et al.Inhibition of apoptosis of activated hepatic stellate cells by tissue inhibitor of metalloproteinase-1 is mediated via effects on matrix metalloproteinase inhibition implications for reversibility of liver fibrosis[J].J Biol Chem, 2002, 277 (13) :11069-11076.
|
|
[9]GOMIS-RUTH FX.Structural aspects of the metzincin clan of metalloendopeptidases[J].Mol Biotechnol, 2003, 24 (2) :157-202.
|
|
[10]EGEBLAD M, WERB Z.New functions for the matrix metalloproteinases in cancer progression[J].Nat Rev Cancer, 2002, 2 (3) :161-174.
|
|
[11]TOKITO A, JOUGASAKI M.Matrix metalloproteinases in non-neoplastic disorders[J].Int J Mol Sci, 2016, 17 (7) :1178.
|
|
[12]JIA HZ, PENG XJ.Effect of matrix metalloproteinases in keratoconus[J].Int Eye Sci, 2016, 16 (9) :1644-1647. (in Chinese) 贾洪真, 彭秀军.基质金属蛋白酶对圆锥角膜的影响[J].国际眼科杂志, 2016, 16 (9) :1644-1647.
|
|
[13]MURPHY G, STANTON H, COWELL S, et al.Mechanisms for pro matrix metalloproteinase activation[J].Apmis, 1999, 107 (1-6) :38-44.
|
|
[14]BREW K, NAGASE H.The tissue inhibitors of metalloproteinases (TIMPs) :an ancient family with structural and functional diversity[J].Biochim Biophys Acta, 2010, 1803 (1) :55-71.
|
|
[15]BREYNAERT C, de BRUYN M, ARIJS I, et al.Genetic deletion of tissue inhibitor of metalloproteinase-1/TIMP-1 alters inflammation and attenuates fibrosis in dextran sodium sulphate induced murine models of colitis[J].J Crohns Colitis, 2016, 10 (11) :1336-1350.
|
|
[16]HERNANDEZ-GEA V, FRIEDMAN SL.Pathogenesis of liver fibrosis[J].Annu Rev Pathol, 2011, 6:425-456.
|
|
[17]ENDO H, NIIOKA M, SUGIOKA Y, et al.Matrix metalloproteinase-13 promotes recovery from experimental liver cirrhosis in rats[J].Pathobiology, 2011, 78 (5) :239-252.
|
|
[18]FALLOWFIELD JA, MIZUNO M, KENDALL TJ, et al.Scar-associated macrophages are a major source of hepatic matrix metalloproteinase-13 and facilitate the resolution of murine hepatic fibrosis[J].J Immunol, 2007, 178 (8) :5288-5295.
|
|
[19]ONOZUKA I, KAKINUMA S, KAMIYA A, et al.Cholestatic liver fibrosis and toxin-induced fibrosis are exacerbated in matrix metalloproteinase-2 deficient mice[J].Biochem Biophys Res Commun, 2011, 406 (1) :134-140.
|
|
[20]SAFADI R, FRIEDRMAN SL.Hepatic fibrosis-role of hepatic stellate cell activation[J].Med Gen Med, 2002, 4 (3) :27-27.
|
|
[21]CAWSTON T, CARRERE S, CATTERALL J, et al.Matrix metalloproteinases and TIMPs:properties and implications for the treatment of chronic obstructive pulmonary disease[J].Novartis Found Symp, 2001, 234:205-218.
|
|
[22]QIAO Z, LI Y, LU H, et al.Expression of tissue levels of matrix metalloproteinases and tissue inhibitors of metalloproteinases in renal cell carcinoma[J].World J Surg Oncol, 2013, 11:1.
|
|
[23]IIMURO Y, NISHIO T, MORIMOTO T, et al.Delivery of matrix metalloproteinase-1 attenuates established liver fibrosis in the rat[J].Gastroenterology, 2003, 124 (2) :445-458.
|
|
[24]KANDASAMY AD, CHOW AK, ALI MA, et al.Matrix metalloproteinase-2 and myocardial oxidative stress injury:beyond the matrix[J].Cardiovasc Res, 2010, 85 (3) :413-423.
|
|
[25]ZOU LL, LIU R, LIU H, et al.Effect of agonists and inhibitorsof matrix metalloproteinases on expression of matrix metall-oproteinase 1/2 and collagen I in human scleral fibroblas[J].Chin J Ophthalmol and Otorhinolaryngol, 2013, 13 (2) :91-95. (in Chinese) 邹蕾蕾, 刘睿, 刘红, 等.MMPs激动剂和抑制剂对人巩膜成纤维细胞MMP1/2以及Ⅰ型胶原表达的作用研究[J].中国眼耳鼻喉科杂志, 2013, 13 (2) :91-95.
|
|
[26]KOONTONGKAEW S, AMOMPHIMOLTHAM P, MONTHANPISUT P, et al.Fibroblasts and extracellular matrix differently modulate MMP activation by primary and metastatic head and neck cancer cells[J].Med Oncol, 2012, 29 (2) :690-703.
|
|
[27]NAGASE H, VISSE R, MURPHY G.Structure and function of matrix metalloproteinases and TIMPs[J].Cardiovasc Res, 2006, 69 (3) :562-573.
|
|
[28]HELALY GF.Differences in circulating MMP-9 levels with regard to viral load and AST:ALT ratio between chronic hepatitis B and Cpatients[J].Br J Biomed Sci, 2011, 68 (1) :38-42.
|
|
[29]RAMACHANDRAN P, IREDALE JP.Liver fibrosis:a bidirectional model of fibrogenesis and resolution[J].QJM, 2012, 105 (9) :813-817.
|
|
[30]LIU J, CHENG X, GUO Z, et al.Truncated active human matrix metalloproteinase-8 delivered by a chimeric adenovirus-hepatitis B virus vector ameliorates rat liver cirrhosis[J].PLoS One, 2013, 8 (1) :e53392.
|
|
[31]SILLER-LOPEZ F, SANDOVAL A, SALGADO S, et al.Treatment with human metalloproteinase-8 gene delivery ameliorates experimental rat liver cirrhosis[J].Gastroenterology, 2004, 126 (4) :1122-1133.
|
|
[32]YANG SW, LEE SM, CHOI EY, et al.Matrix metalloproteinase‐1 induces cleavage of exogenous alphab-crystallin transduced by a cell‐penetrating peptide[J].J Cell Biochem, 2011, 112 (9) :2454-2462.
|
|
[33]KUO TK, HUNG SP, CHUANG CH, et al.Stem cell therapy for liver disease:parameters governing the success of using bone marrow mesenchymal stem cells[J].Gastroenterology, 2008, 134 (7) :2111-2121, e1-e3.
|
DownLoad: